Biological solutions that reduce consumption and drive growth
A future economy for Canada will rely on the biosciences to drive sustainable growth. This bio-revolution is worth an estimated US$4 trillion. Federal strategies and initiatives including the Biomanufacturing and Life Sciences Strategy, Bioeconomy Strategy and circular economy initiatives are building domestic capacity in biomanufacturing from health, to agriculture, to forestry and mining. Genomics in Canada is already addressing sustainable biomanufacturing across industries, showcasing the value of biological solutions to futureproofing all sectors of the economy. For example, supporting infrastructure for health biomanufacturing to be prepared for future pandemics; developing cellular agriculture for new protein sources; the translation of forestry pulp fractions into upgraded biopolymers is valorizing prior waste products; and using bioprocessing to extract value from mining waste. In addition to supporting biomanufacturing infrastructure and projects, we are investing in the future bio-workforce, and that is core to delivering broad benefits to Canadians.
With collaboration across the Canadian Genomics Enterprise.
